NCT02450045

Brief Summary

Hip fractures (broken hips) are common in older people, particularly older women with fragile bones, and usually occur with a simple fall from a standing height. In Canada, over 28,000 hip fractures occur every year, and approximately 900 occur in Edmonton. After a hip fracture, up to 50% of those who survive their hip fracture do not recover to the same level of activity that they had before breaking their hip. Managing pain with any broken bone is very important. For patients with hip fracture, their older age and fragile health makes pain management even more challenging. Many patients with a hip fracture have reduced ability to think clearly before the fracture. Some patients who have no difficulty with thinking before their hip fracture will become confused for a brief period after their hip fracture or can develop permanent difficulties with thinking. A hip fracture will usually require an operation, and choosing the right pain medication before and after the operation is important since many pain medications make confusion more likely. Permanent difficulty with thinking is a common reason for poor recovery after hip fracture. Our study will look at use of a nerve block to manage pain before patients have their operation. A nerve block provides local pain relief without requiring patients to take the medication by mouth (oral) or through an intravenous (IV) route. A nerve block before surgery may reduce the amount of oral and IV pain medication needed by the patient both before and after their operation but still provide good pain control with less confusion. This could lead to better recovery and allow more patients to return to living in the community rather than long-term care.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 12, 2015

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 21, 2015

Completed
11 days until next milestone

Study Start

First participant enrolled

June 1, 2015

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
Last Updated

March 25, 2020

Status Verified

March 1, 2020

Enrollment Period

4.6 years

First QC Date

May 12, 2015

Last Update Submit

March 23, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pain at rest

    Visual Analogue Scale and Checklist of Non-verbal Pain Indicators

    up to 5 days post-operative

  • Pain upon movement

    Visual Analogue Scale and Checklist of Non-verbal Pain Indicators

    up to 5 days post-operative

Secondary Outcomes (2)

  • Cognitive function

    up to 5 days post-operative

  • Analgesia consumption

    up to 5 days post-operative

Study Arms (2)

Femoral nerve block

ACTIVE COMPARATOR

Patients will receive a pre-operative continuous femoral nerve block.

Procedure: Continuous femoral nerve blockDrug: 0.5% Ropivacaine/0.125% Bupivacaine local anesthetic mixture

Control

NO INTERVENTION

Patients will receive standard care without a continuous femoral nerve block.

Interventions

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Ambulatory pre-fracture
  • Sustained a low-energy hip fracture (i.e., fall from standing)
  • Mini Mental Status Examination (MMSE) score of 13 (moderate dementia) or greater
  • Consent to participate in study

You may not qualify if:

  • Failure to obtain consent
  • Admitted to hospital more than 30 hours from injury
  • Regular use of opiate medications
  • Confusion Assessment Method (CAM) test not performed within 6 hours of ward admission
  • Known allergy to local anesthetic

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta Hospital

Edmonton, Alberta, T6G 2G3, Canada

Location

Related Publications (2)

  • Beaupre LA, Johnston DB, Dieleman S, Tsui B. Impact of a preemptive multimodal analgesia plus femoral nerve blockade protocol on rehabilitation, hospital length of stay, and postoperative analgesia after primary total knee arthroplasty: a controlled clinical pilot study. ScientificWorldJournal. 2012;2012:273821. doi: 10.1100/2012/273821. Epub 2012 Apr 30.

    PMID: 22666096BACKGROUND
  • Guay J, Kopp S. Peripheral nerve blocks for hip fractures in adults. Cochrane Database Syst Rev. 2020 Nov 25;11(11):CD001159. doi: 10.1002/14651858.CD001159.pub3.

MeSH Terms

Conditions

Hip Fractures

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 12, 2015

First Posted

May 21, 2015

Study Start

June 1, 2015

Primary Completion

January 1, 2020

Study Completion

January 1, 2020

Last Updated

March 25, 2020

Record last verified: 2020-03

Locations